![Simon Lowry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 30/06/2026
Dr. Simon Lowry, MD, is a Chief Medical Officer, Head-Research & Development at Emergent BioSolutions, Inc. Dr. Lowry was previously employed as a Chief Executive Officer by Mysthera Therapeutics AG.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/04/2026 | 177.914 ( 0,34 % ) | 1 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Director Técnico/Científico/I+D | 18/11/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Mysthera Therapeutics
 Mysthera Therapeutics BiotechnologyHealth Technology Operates as a biotech start-up intended for developing oral therapeutics | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Mysthera Therapeutics
Mysthera Therapeutics BiotechnologyHealth Technology Operates as a biotech start-up intended for developing oral therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
